Access to Medicines. Without Delay. Without Borders.

New medicines are being developed every day. But global approval timelines are long, and not every treatment becomes available in every country.

 

At ATP Rx, we specialize in designing and delivering compliant, scalable, and patient-focused access programs for pharmaceutical manufacturers, clinical research organizations, and healthcare systems.

Regulatory Foresight

Access strategy built on early identification of regulatory pathways, jurisdictional nuances, and risk points.

Program Architecture

Custom frameworks designed to align with product status, therapeutic urgency, and market entry timelines.

Operational Continuity

Seamless coordination across sourcing, distribution, and compliance to ensure uninterrupted patient reach.

Our Core Services

Comprehensive solutions that address every phase of the product lifecycle

Expanded Access Programs (EAP)

Provide pre-approval access to investigational drugs for patients with serious or life-threatening conditions outside of clinical trials.

Post-Trial Access Programs

Ensuring continued treatment for clinical trial participants after a study ends, until the therapy becomes locally available.

Post-Approval Named Patient Programs

Enable patient access in countries where the medicine is approved internationally but not yet available locally.

Special Access Program

Navigate Canada’s regulatory framework for unapproved therapies, ensuring compliance and streamlined delivery to physicians and patients.

Market Access Solutions

Support early engagement with stakeholders, pricing strategy, payer alignment, and phased product entry to accelerate time to market.

Enablement!

Expertise Beyond Supply

Access is about more than sourcing medicines. It requires a nuanced understanding of regulatory frameworks, therapeutic value, patient need, and operational logistics - across multiple jurisdictions.

With deep therapeutic knowledge and proven experience across Canada and global markets, we support you in:

 

  • Evaluating access pathways and compliance risk

  • Managing regulatory submissions and Health Canada engagements

  • Designing and operationalizing tailored access programs

  • Coordinating end-to-end supply chain and pharmacovigilance

  • Facilitating meaningful access with speed, transparency, and control

Let’s Build Access, Together

If you’re looking for a strategic partner who can translate intent into action, we’re ready to collaborate.